Carlos González-Juanatey Selected Research

Carlos González-Juanatey Research Topics

Disease

21	Inflammation (Inflammations) 01/2021 - 12/2011
21	Rheumatoid Arthritis 07/2020 - 06/2011
15	Ankylosing Spondylitis 01/2021 - 11/2012
15	Atherosclerosis 01/2016 - 05/2011
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2011
10	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2016 - 05/2013
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 02/2016
6	Insulin Resistance 01/2014 - 11/2012
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2016
3	Stroke (Strokes) 01/2022 - 01/2013
3	Rheumatic Diseases (Rheumatism) 01/2021 - 06/2012
3	Pulmonary Embolism 09/2012 - 09/2010
2	Heart Failure 05/2022 - 10/2019
2	Cardiomyopathies (Cardiomyopathy) 05/2022 - 01/2022
2	Obesity 01/2021 - 11/2012
2	Hypersensitivity (Allergy) 09/2019 - 12/2018
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2019 - 01/2019
2	Diabetes Mellitus 01/2019 - 01/2018
2	Chronic Renal Insufficiency 01/2018 - 01/2008
2	Necrosis 05/2014 - 07/2013
1	Syncope (Fainting) 05/2022
1	Ischemic Stroke 01/2022
1	Unstable Angina 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Atrial Fibrillation 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Heart Valve Diseases (Valvular Heart Disease) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Acute Coronary Syndrome 01/2021
1	Spontaneous Coronary Artery Dissection 01/2020
1	Takotsubo Cardiomyopathy 11/2019
1	Arthritis (Polyarthritis) 01/2017
1	Pain (Aches) 12/2015
1	Carotid Artery Diseases 03/2014

Drug/Important Bio-Agent (IBA)

19	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2011
8	Infliximab (Remicade)FDA Link 09/2014 - 11/2012
7	AdipokinesIBA 11/2016 - 01/2013
5	OsteoprotegerinIBA 11/2016 - 01/2014
4	Insulin (Novolin)FDA Link 01/2022 - 01/2014
4	Anti-Citrullinated Protein AntibodiesIBA 01/2014 - 01/2012
3	MagnesiumIBA 01/2020 - 12/2018
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 11/2012
3	Monoclonal AntibodiesIBA 11/2013 - 11/2012
2	Amyloid (Amyloid Fibrils)IBA 05/2022 - 01/2022
2	Prealbumin (Transthyretin)IBA 05/2022 - 01/2022
2	Cyclophilin CIBA 01/2022 - 01/2019
2	Rheumatoid FactorIBA 01/2021 - 06/2012
2	Cyclophilins (Cyclophilin)IBA 01/2021 - 01/2019
2	NickelIBA 09/2019 - 12/2018
2	SmokeIBA 01/2018 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 12/2011
2	AdiponectinIBA 11/2016 - 05/2013
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 11/2016 - 09/2013
2	ApelinIBA 12/2015 - 07/2013
2	Angiopoietin-2IBA 09/2013 - 07/2013
2	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 09/2012 - 09/2010
1	pro-brain natriuretic peptide (1-76)IBA 05/2022
1	AcidsIBA 05/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2022
1	Clopidogrel (Plavix)FDA Link 01/2022
1	SultanIBA 01/2022
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Vitamin K FDA Link 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	amsonic acid (DAS)IBA 01/2021
1	InterleukinsIBA 01/2021
1	Cyclophilin AIBA 01/2021
1	Cell Surface ReceptorsIBA 01/2021
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 07/2020
1	ApolipoproteinsIBA 07/2020
1	Adenosine (Adenocard)FDA LinkGeneric 11/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	ImmunophilinsIBA 01/2019
1	CholesterolIBA 01/2018
1	CalciumIBA 01/2018
1	Lipoprotein(a)IBA 05/2017
1	Lipoproteins (Lipoprotein)IBA 05/2017
1	Interleukin-5 (Interleukin 5)IBA 01/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	HLA-DRB1 Chains (HLA DRB1)IBA 11/2016
1	EpitopesIBA 11/2016
1	Calcitriol Receptors (Calcitriol Receptor)IBA 02/2016
1	GATIBA 02/2016
1	C-Reactive ProteinIBA 01/2016
1	Fibrinogen (Factor I)FDA Link 01/2016
1	25-hydroxyvitamin DIBA 08/2015
1	hydroxide ionIBA 08/2015
1	Interleukin-33IBA 01/2015
1	Interferon Regulatory FactorsIBA 07/2014
1	LipidsIBA 07/2014
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 05/2014
1	AutoantibodiesIBA 03/2014
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2014
1	Insulin-Like PeptidesIBA 01/2014

Therapy/Procedure

19	Therapeutics 01/2022 - 05/2011
3	Percutaneous Coronary Intervention 01/2022 - 12/2018
2	Biological Therapy 05/2017 - 01/2013